DX Group
DX
$13.03
-1.66%
Dynex Capital, Inc. is a real estate investment trust (REIT) that invests primarily in agency residential and commercial mortgage-backed securities (MBS), which are guaranteed by U.S. government-sponsored enterprises, and generates income from the spread between yields on these assets and its funding costs. As an internally managed mortgage REIT, it distinguishes itself through a focus on agency MBS, which carry lower credit risk but are sensitive to interest rate and prepayment dynamics. The current investor narrative centers on the company's ability to sustain its dividend and book value amid fluctuating interest rates and mortgage spreads, with recent quarterly results showing a net loss due to mark-to-market losses, while the stock trades near the lower end of its 52-week range, reflecting concerns about the interest rate environment and the sustainability of earnings.…
DX
DX Group
$13.03
Investment Opinion: Should I buy DX Today?
Based on the analysis, DX is rated a Hold. The stock offers a high dividend yield of 14.2% and trades at a 29% discount to book value, but the recent net loss and high leverage introduce significant uncertainty. The average analyst target of $14.75 implies 13.2% upside, but the narrow coverage and mixed recommendations suggest limited conviction. The thesis is that DX can generate sufficient income from its MBS portfolio to maintain the dividend, but this depends on stable interest rates and mortgage spreads.
Sign up to view all
DX 12-Month Price Forecast
The AI assessment is neutral, as the stock offers a compelling valuation and high income, but the recent loss and leverage create significant uncertainty. The key factor is the direction of interest rates: if they stabilize, DX could re-rate higher; if they rise, the stock could suffer. Upgrading to bullish would require evidence of sustainable profitability, such as two consecutive quarters of positive net income and stable book value. Downgrading to bearish would occur if the dividend is cut or book value declines materially.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on DX Group's 12-month outlook, with a consensus price target around $14.75 and implied upside of +13.2% versus the current price.
Average Target
$14.75
0 analysts
Implied Upside
+13.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$15 - $15
Analyst target range
Analyst coverage is limited to 5 analysts, with a consensus recommendation of 'none' (likely a mix of Hold and Buy ratings). The average target price is $14.75, implying an upside of 13.2% from the current price of $13.03. The target range is $14.50 to $15.00, with a narrow spread of $0.50, indicating relatively high conviction among the few analysts covering the stock. The high target of $15.00 suggests expectations of a recovery in book value and dividend sustainability, while the low target of $14.50 still implies a 11.3% upside, reflecting a generally positive outlook. Institutional ratings show a mix of Buy and Outperform from Jones Trading and KBW, with UBS maintaining a Neutral stance, indicating a cautiously optimistic sentiment.
Bulls vs Bears: DX Investment Factors
The bull case rests on DX's explosive revenue growth, deep discount to book value, and attractive dividend yield, which together suggest the market is overly pessimistic. However, the bear case is compelling due to the Q1 net loss, high leverage, and persistent underperformance relative to the market. The most critical tension is whether the recent revenue expansion can translate into sustainable profitability and book value growth, or whether rising interest rates will continue to erode earnings. Currently, the bearish evidence is slightly stronger given the recent loss and high leverage, but the valuation discount and analyst targets provide a margin of safety. The stock's fate hinges on the direction of interest rates and mortgage spreads, which will determine if the dividend and book value can be maintained.
Bullish
- Revenue growth accelerating sharply: Q1 2026 revenue surged 170.8% YoY to $257.4M, driven by a major expansion in the MBS portfolio. This growth is exceptional for a mortgage REIT and signals successful capital deployment.
- Deep discount to book value: The stock trades at a P/B ratio of 0.71x, well below the historical average of ~0.8x. This suggests the market is pricing in a permanent impairment of book value, which may be overly pessimistic given the agency MBS portfolio's credit quality.
- Analyst targets imply solid upside: The average analyst target is $14.75, representing 13.2% upside from the current price of $13.03. Even the low target of $14.50 implies an 11.3% gain, indicating that analysts see the stock as undervalued.
- High dividend yield with coverage: The dividend yield is 14.2%, and the payout ratio is 77.3% based on trailing earnings, suggesting the dividend is currently covered. This provides a substantial income cushion for investors.
Bearish
- Net loss in Q1 2026: The company reported a net loss of $80.4M in Q1 2026, compared to a small loss of $3.1M a year ago. This was driven by a $178.1M interest expense and mark-to-market losses, highlighting the vulnerability to rising rates.
- High leverage amplifies risk: The debt-to-equity ratio is 5.65x, indicating significant reliance on borrowed funds. This leverage magnifies both gains and losses, making earnings highly sensitive to interest rate movements.
- Underperformance vs. market: Over the past year, DX returned +4.8% while the S&P 500 gained 20.5%, a relative underperformance of 15.7 percentage points. This suggests persistent negative sentiment and a lack of momentum.
- Forward PE implies earnings decline: The forward PE of 8.31x is higher than the trailing PE of 5.63x, indicating that analysts expect earnings to fall from current levels. This is consistent with the recent quarterly losses and raises concerns about dividend sustainability.
DX Technical Analysis
Over the past year, DX has exhibited a range-bound to slightly positive trend, with a 1-year price change of +4.83%, while the S&P 500 gained 20.48% over the same period, indicating significant underperformance. The stock is currently trading at $13.03, which is 87.3% of its 52-week range (low of $11.83, high of $14.93), placing it closer to the lower end of the range, suggesting a lack of momentum and potential value or a falling knife scenario. The 6-month price change is -7.78%, and the year-to-date change is -7.46%, reinforcing a bearish intermediate-term trend despite the positive 1-year figure.
Beta
0.94
0.94x market volatility
Max Drawdown
-17.4%
Largest decline past year
52-Week Range
$12-$15
Price range past year
Annual Return
+4.8%
Cumulative gain past year
| Period | DX Return | S&P 500 |
|---|---|---|
| 1m | +0.6% | +3.6% |
| 3m | +2.4% | +2.7% |
| 6m | -7.8% | +11.4% |
| 1y | +4.8% | +18.7% |
| ytd | -7.5% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DX Fundamental Analysis
Revenue has grown strongly, with the most recent quarter (Q1 2026) reporting revenue of $257.39 million, up 170.77% year-over-year from $95.06 million in Q1 2025, driven by a significant expansion in the MBS portfolio. However, this growth is accompanied by a net loss of $80.36 million in Q1 2026, compared to a net loss of $3.08 million in the year-ago quarter, reflecting the impact of higher interest expenses and mark-to-market losses. The company's gross margin is 100% as is typical for a REIT, but the net margin is -31.22% in Q1 2026, indicating that expenses, particularly interest expense of $178.14 million, have outpaced revenue growth.
Quarterly Revenue
$257390000.0B
2026-03
Revenue YoY Growth
+170.8%
YoY Comparison
Gross Margin
100.0%
Latest Quarter
Free Cash Flow
$184307000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DX Overvalued?
Given that the trailing twelve-month net income is positive (based on the most recent four quarters, which include a large Q4 2025 profit), the PE ratio is the primary valuation metric. The trailing PE is 5.63x, while the forward PE is 8.31x, implying that the market expects earnings to decline, which is consistent with the recent quarterly losses. The stock trades at a price-to-book ratio of 0.71x, which is below the historical average of around 0.8x, suggesting a discount to book value. Compared to the industry average PE for mortgage REITs, which typically ranges from 8-12x, DX's trailing PE of 5.63x appears cheap, but this is due to the volatile earnings; the forward PE of 8.31x is more in line with peers, indicating the market is pricing in a normalization of earnings.
PE
5.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 1x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are elevated due to DX's high leverage, with a debt-to-equity ratio of 5.65x. This amplifies the impact of interest rate changes on net income, as evidenced by the Q1 2026 net loss of $80.4M, driven by $178.1M in interest expense. The company's earnings are highly volatile, swinging from a $185.4M profit in Q4 2025 to a loss in Q1 2026, making it difficult to predict future cash flows. Additionally, the payout ratio of 77.3% leaves little room for error if earnings decline, potentially forcing a dividend cut. The reliance on short-term repurchase agreements for funding exposes DX to rollover risk and liquidity constraints in stressed markets.
FAQ
The key risks are: 1) Interest rate risk - rising rates could cause mark-to-market losses and increase borrowing costs, as seen in Q1 2026. 2) Leverage risk - the debt-to-equity ratio of 5.65x amplifies losses. 3) Dividend risk - the payout ratio of 77.3% leaves little room for error, and a dividend cut is possible if earnings decline. 4) Market risk - the stock has underperformed the S&P 500 by 15.7 percentage points over the past year, indicating negative sentiment. These risks are ranked by severity, with interest rate risk being the most significant.
The 12-month forecast is mixed, with a base case probability of 45% for a price range of $13.50-$14.50, a bull case probability of 30% for $14.50-$15.00, and a bear case probability of 25% for $11.83-$12.50. The base case assumes stable interest rates and continued dividend payments, while the bull case requires a more favorable rate environment. The bear case would materialize if rates rise sharply or the dividend is cut. The most likely outcome is a modest gain, with the stock trading near the analyst average target of $14.75.
DX appears undervalued based on its price-to-book ratio of 0.71x, which is below the historical average of 0.8x. The trailing PE of 5.63x is also low, but this is due to volatile earnings; the forward PE of 8.31x is more in line with peers. The market is pricing in a decline in earnings, which is consistent with the recent losses. Overall, the stock is trading at a discount to book value, suggesting the market is skeptical about the sustainability of its book value and dividend. If the company can stabilize earnings, the valuation could re-rate higher.
DX offers a high dividend yield of 14.2% and trades at a 29% discount to book value, which could provide a margin of safety. However, the recent net loss of $80.4M in Q1 2026 and high leverage (D/E 5.65x) introduce significant risk. The average analyst target of $14.75 implies 13.2% upside, but the stock is only suitable for investors who can tolerate volatility and are comfortable with the risks of a leveraged mortgage REIT. It may be a good buy for income-focused investors who believe interest rates will stabilize, but it is not a core holding for conservative portfolios.
DX is more suitable for short-term trading or income generation rather than long-term growth, given its high volatility and sensitivity to interest rates. The stock's beta of 0.935 and recent price swings make it a poor candidate for buy-and-hold investors seeking stability. For income investors, a minimum holding period of 1-2 years is recommended to capture the dividend yield, but they must be prepared for significant price fluctuations. Long-term investors should avoid DX unless they have a strong conviction that interest rates will remain low and the dividend is sustainable.